Sponsoring Organization: Centers for Disease Control and Prevention (CDC)Background and Objectives: To assist healthcare practitioners in the screening, detection, and treatment of sexually transmitted infections (STIs; replaces the term sexually transmitted diseases [STDs]) in various patient populations and clinical settings
Key Points and Recommendations
Antimicrobial regimens for numerous STIs are provided; most are similar to those in the previous guidelines (NEJM JW Infect Dis Jun 18 2015 and MMWR Morb Mortal Wkly Rep 2015; 64:1).
What Has Changed
The regimen for gonococcal infection now consists of a single intramuscular dose of ceftriaxone (500mg).
Regimens for HIV/AIDS have been consolidated, with improvements in effectiveness and reduc…
Reviewing Author
DisclosuresConsultant/Advisory BoardClinical Infectious Diseases
RoyaltiesUpToDate
Editorial BoardsMedical Letter
DisclosuresConsultant/Advisory BoardClinical Infectious Diseases
RoyaltiesUpToDate
Editorial BoardsMedical Letter